Core Viewpoint - The company, Tengsheng Bo Pharmaceutical-B (02137), announced the granting of 600,000 stock options under its 2023 stock option plan, pending acceptance by the grantees [1] Summary by Relevant Sections - Stock Options Granted - The company will grant 600,000 stock options to grantees as per the terms of the 2023 stock option plan [1] - Current Share Issuance - As of the announcement date, the total number of issued shares is 720.9 million (excluding treasury shares) [1] - Impact of Stock Options on Shares - If the granted stock options are fully exercised, the new shares to be issued will represent approximately 0.08% of the total issued shares as of the announcement date (excluding treasury shares) and also approximately 0.08% of the enlarged total issued shares (excluding treasury shares) [1]
腾盛博药-B(02137)授出60万份购股权